Albert Nassir, MD
Family Medicine · Los Angeles, CANPI 1821161860
Payments from drug & device makers
What this record shows
Sanofi Pasteur Inc. accounts for 63.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,179 and has fallen 97.5% since, to $30 in 2025.
Across 24 payments — averaging $73.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$1K
- Acadia Pharmaceuticals Inc$246
- Teva Pharmaceuticals USA, Inc.$121
- Hologic Sales And Service, LLC$82
- Merck$37
- Bayer$35
- plus $120 from 5 others
Across 230 payments — averaging $24,830 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bavarian Nordic A/s$3M
- Abbott$1.6M
- Sanofi Pasteur Inc.$549K
- Pfizer$380K
- GSK$178K
- Modernatx, Inc.$20K
What the payments were for
- Travel & lodging$81446%
- Food & beverage$95254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 8 | $1,124 |
| Acadia Pharmaceuticals Inc | 2 | $246 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Hologic Sales And Service, LLC | 4 | $82 |
| Merck | 2 | $37 |
| Bayer | 1 | $35 |
| Minerva Surgical, Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| AbbVie | 1 | $25 |
| Pfizer | 1 | $21 |
| Seagen Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO PRODUCT DISCUSSED$1,014
- NUPLAZID$246
- Austedo XR$121
How this compares
$1,765 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $995 |
| Metronidazole | 12 | $359 |
| Ibuprofen | 12 | $33 |
| Famotidine | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Los Angeles
- Pamela KushnerLos Angeles$1.2M
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Jacqueline KenneyLos Angeles$121K
- Sherly SoleimanEncino$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.